TG Therapeutics Inc (TGTX)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 23,383 | 12,672 | -198,335 | -348,101 | -279,381 |
| Revenue | US$ in thousands | 324,397 | 221,047 | 2,785 | 6,689 | 152 |
| Net profit margin | 7.21% | 5.73% | -7,121.54% | -5,204.08% | -183,803.29% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $23,383K ÷ $324,397K
= 7.21%
Based on the provided data, the net profit margin for TG Therapeutics Inc has shown significant fluctuations over the years. In December 31, 2020, the net profit margin was remarkably low at -183,803.29%, indicating that the company incurred significant losses exceeding its revenue. However, there has been a notable improvement in the company's performance by December 31, 2024, with a net profit margin of 7.21%, signifying that the company is generating profit relative to its revenue.
It is important to note that negative net profit margins suggest that the company's expenses surpass its revenues, leading to losses, while positive net profit margins are indicative of a successful operational performance where revenue exceeds expenses. The positive trend from 2020 to 2024 indicates that TG Therapeutics Inc has been able to better manage its costs and enhance its profitability over the years.
Peer comparison
Dec 31, 2024